XORTX Therapeutics Inc.
- XRTX
- NASDAQ
- Biotechnology
- Chronic Kidney Disease Drugs
- Diabetes/Metabolic Disease Drugs
$1.24
Today −12.68%Quote Oct 16, 2026, 08:00 PM UTC
−25.30%over the last month
Max drawdown −35.4%From 1-month high −35.4%3 months −38.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.0M
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.15
7.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about XRTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
2